Disclosure of innovation activities by high-technology firms

Asia-Pacific Journal of Accounting and Economics

Volumn 10, Issue 2, 2003, Pages 143-172

  Gu, Feng ^a   Li, John Q ^b  

^a BOSTON UNIVERSITY   (United States)

^b SUFFOLK UNIVERSITY   (United States)

Author keywords

disclosure; high technology; innovation; value relevance

Indexed keywords

EID: 36248936584     PISSN: 16081625     EISSN: 21642257     Source Type: Journal    
DOI: 10.1080/16081625.2003.10510623     Document Type: Article

References (41)

1. Aboody, D. and Lev, B. 2000. “Information asymmetry, R&D, and insider gains”. Journal of Finance, 55: 2747–2766.
2. Belsley, D., Kuh, E. and Welsch, R. 1980. Regression diagnostics New York: John Wiley & Sons, Inc.
3. Botosan, C. 1997. “Disclosure level and the cost of equity capital”. The Accounting Review, 72: 323–349.
4. Bowen, R. and Shores, D. 2000. “Economic context and the value relevance of accounting data”. In Working Paper University of Washington.
5. Campbell, J., Lo, A. and MacKinlay, A. 1997. The econometrics of financial markets Princeton, N.J.: Princeton University Press.
6. Chen, S., DeFond, M. L. and Park, C. W. 2002. “Voluntary disclosure of balance sheet information in quarterly earnings announcements”. Journal of Accounting and Economics, 33: 229–251.
7. Clarkson, P., Kao, J. and Richardson, G. 1994. “The voluntary inclusion of forecasts in the MD&A section of annual reports”. Contemporary Accounting Research, 11: 423–450.
8. Cohen, L. 1992. “Some biotech firms excel at state-of-art hype”. In Wall Street Journal (March 13) CI
9. Cohen, W., Nelson, R. and Walsh, J. 2000. “Protecting their intellectual assets: Appropriability conditions and why U.S. manufacturing firms patent (or not)”. In Working Paper Carnegie Mellon University.
10. Collins, D., Maydew, E. and Weiss, I. 1997. “Changes in the value relevance of earnings and book values over the last forty years”. Journal of Accounting and Economics, 24: 39–67.
11. Darby, M., Liu, Q. and Zucker, L. 1999. “Stakes and stars: The effect of intellectual human capital on the level and variability of high-tech firms' market values”, Working Paper 7201 National Bureau of Economic Research.
12. Dye, R. 1985. “Disclosure of nonproprietary information”. Journal of Accounting Research, 23: 123–145.
13. Ely, K., Simko, P. and Thomas, L. G. 2002. “The usefulness of biotechnology firms' drug development status in the evaluation of research and development costs”. In Working Paper Georgia Institute of Technology.
14. Fama, E. and French, K. 1992. “The cross-section of expected stock returns”. Journal of Finance, 47 427465
15. FASB (Financial Accounting Standards Board). 2001a. “Proposal for a new agenda project: Disclosure on information about intangible assets not recognized in financial statements
16. FASB (Financial Accounting Standards Board). 2001b. “Improving business reporting: Insights into enhancing voluntary disclosures”, Steering committee report, business reporting project
17. Francis, J., Philbrick, D. and Schipper, K. 1994. “Shareholder litigation and corporate disclosures”. Journal of Accounting Research, 32: 137–164.
18. Frankel, R., McNichols, M. and Wilson, G. P. 1995. “Discretionary disclosure and external financing”. The Accounting Review, 70: 135–150.
19. Grossman, S. 1981. “The informational role of warranties and the private disclosure about product quality”. Journal of Law and Economics, 24: 461–483.
20. Gu, F. and Lev, B. 2002. “On the relevance and reliability of R&D”. In Working Paper New York University.
21. Harris, M. 1998. “The association between competition and manager's business segment reporting choices”. Journal of Accounting Research, 36: 111–128.
22. Hayn, C. 1995. “The information content of losses”. Journal of Accounting and Economics, 20: 125–153.
23. Healy, P., Hutton, A. and Palepu, K. 1999. “Stock performance and intermediation changes surrounding sustained increases in disclosure”. Contemporary Accounting Research, 16 (3): 485–520.
24. International Accounting Standards Committee (IASC). 1998. “Intangible assets”, International Accounting Standards No. 38 London
25. Jones, C. and Weingram, S. 1996. “The determinants of 10b-5 litigation risk”. In Working Paper Stanford University.
26. King, R., Pownall, G. and Waymire, G. 1990. “Expectations adjustment via timely management forecasts: Review, synthesis and suggestions for future research”. Journal of Accounting Literature, 9: 113–144.
27. Kothari, S. P., Laguerre, T. and Leone, A. 2002. “Capitalization versus expensing: Evidence on the uncertainty of future earnings from capital expenditures versus R&D outlays”. Review of Accounting Studies, 7 (4): 355–382.
28. Lang, M. 1991. “Time-varying stock price response to earnings induced by uncertainty about the time-series process of earnings”. Journal of Accounting Research, 29: 229–257.
29. Lang, M. and Lundholm, R. 1993. “Cross-sectional determinants of analyst ratings of corporate disclosure”. Journal of Accounting Research, 31: 246–271.
30. Lev, B. 2001. Intangibles: management, measurement, and reporting Washington, D.C.: Brookings Institution Press.
31. Lev, B. and Zarowin, P. 1999. “The boundaries of financial reporting and how to extend them”. Journal of Accounting Research (Supplement),: 353–385. 37
32. Levin, R., Klevorick, A., Nelson, R. and Winter, S. 1987. “Appropriating the returns from industrial R&D”. Brookings Papers on Economic Activity,: 783–820.
33. Lundholm, R. and Myers, L. 2002. “Bringing the future forward: The effect of disclosure on the returns- earnings relation”. Journal of Accounting Research, 40: 809–839.
34. Mansfield, E. and Wagner, S. 1977. The production and application of new industrial technology New York, N.Y.: Norton.
35. Securities and Exchange Commission (SEC). 2001. “Strengthening financial markets: Do investors have the information they need?” report by the SEC-Inspired Task Force
36. Sengupta, P. 1998. “Corporate disclosure quality and the cost of debt”. The Accounting Review, 73: 459–174.
37. Shortridge, R. 2000. “Measuring R&D success: A study of new drug approvals in the pharmaceutical industry”. In Working Paper Ball State University.
38. Skinner, D. 1994. “Why firms voluntarily disclose bad news?”. Journal of Accounting Research, 32: 38–60.
39. Tasker, S. 1998. “Bridging the information gap: Quarterly conference calls as a medium for voluntary disclosure”. Review of Accounting Studies, 3: 137–167.
40. Verrecchia, R. 1983. “Discretionary disclosure”. Journal of Accounting and Economics, 32: 97–108.
41. Watts, R. and Leftwich, R. 1977. “The time series of annual accounting earnings”. Journal of Accounting Research, 15: 253–271.